Angel Invest is a self-described most active Angel Fund in Europe that makes angel investments into European technology startups. Angel Invest focuses on Pre-seed and Seed rounds with an initial check size of €100k.

Angel Invest

Angel Invest is one of Europe's most active angel funds. We make 50+ investments per year and coach founders through to Series A.

alcemy raises $10M to advance cement decarbonisation https://buff.ly/45THHTN

How would you like to have visibility on more than 550 fund managers / venture capital funds actively investing across Europe? Across early and growth stage? No strings attached? See below..

Last year, I launched a side-project showcasing the top 80 funds in Europe (& their investment teams) investing in UK pre-Seed and Seed stage startups. After working for and with accelerators since 2016, I wanted to support the many founders I have worked with in acquiring better visibility on which funds they should be approaching (& how - one for a separate discussion). This year, teaming up with Jens Lapinski, Jag Singh and Angel Invest, we’ve now mapped out 550 fund managers / venture capital funds actively investing across Europe – with a whole lot of extra data that you can gain value from. This includes:

🚀  Investment focus – The sectors/verticals/business models they invest in.

🚀  Stage – The stage/s they invest in & distribution % of first check investments by stage over the last five years, according to CB.

🚀  Geo – The geo’s they invest in & distribution % of first check investments by geo over the last five years, according to CB.

🚀  Portfolio construction – The number of funds, when they closed their latest fund, size of that fund, investment range, number of companies they intend to invest in (with that fund), as well as how much reserve % they have for follow-on investments.

We believe it will be incredibly valuable to multiple different people in the startup and venture capital ecosystem. To founders, when raising investment and building out their investor pipelines. To venture capital teams, when supporting your portfolio companies raise OR for visibility of funds actively investing across Europe. To angel investors, when supporting your portfolio founders raise their next round. To start-up service providers, there are many ways you can leverage this. But a big one we've already seen is LP's, giving you full visibility of the active fund managers investing across Europe. Interested? See the list below:

🚀 https://lnkd.in/dVjZ2U9A

If you have any feedback, drop us a note in the comments or shoot us a direct message. It was a huge amount of work and curation with many of the investors in the database (big thank you again - I've only been able to tag a small number). Please do share with others - the aim is for anyone and everyone to have access to the data, at anytime, and to gain value from 😎

We love kencko's products and there is nothing better than working with a founder who turned his passion into a company. You can feel the energy every day and not even a fire can stop Tomás Froes on his way. Great to see how many more people are benefiting from Kencko's products.

🚀 Exciting News from Vivalyx! 🚀

We are thrilled to announce the successful closure of our oversubscribed Seed funding round, raising over €5 million! This marks a pivotal moment for us as we finance the clinical studies for our groundbreaking organ preservation technology.

A heartfelt thank you to our new and existing investors, including Brightlands Venture Partners, TVF | TechVision Fonds, GOOSE Capital, Andrej Henkler, Angel Invest, Arve Capital and Springboard Health Angels. Your faith in our vision energizes our mission to revolutionize organ transplantation.

Read more about how we're planning to extend vitality of donor organs for a significant impact on healthcare systems worldwide.

https://lnkd.in/ecXWM63P

Have you considered organ donation for yourself? Join the discussion and share your thoughts! 💙
 
Our supporters: Alexander Luik, Priv.-Doz. Dr. med. Alexander Younsi, FEBNS, Andreas Schmidt (PhD.), Andrej Henkler, Angel Invest (Jens Lapinski, John von Berenberg-Consbruch), Ariel Dora Stern, Arve Capital (Christian Schierholz, Philipp Harnischfeger), Ashok Rao, Audrey Tsang, Bernd Heinrichs, Brightlands Venture Partners (Luc Starmans), Dr. Carina Ruwolt, Christian Stiebner, Christopher Oezbek, Dr. Daniel Schellong, David Greenberg, GOOSE Capital (Andrew Nicholson), Ingo Hillen, Jan Adams, Katharina Klohe, Klaus-Dieter Langner, Lisa Ernst, Nicolas Weber, Dr. Ole Dammann, Sebastian Johnston, Till Erdmann, Troy Dale, TVF | TechVision Fonds (Bernhard Kugel, Dr. Lars Gussen), Dr. Valentin Schmitt, Dr. Yoni Goldwasser
 
#Vivalyx #TechnologySavesTheWorld #MedTech #OrganTransplantation #OrganDonation #Innovation #LifeScience

Angel Invest Coaching #6 Our View on the Macro. Summary: Q3 2023 was the bottom in the private tech market. Now on the upswing, good visibility of behaviour and prices.

Thank you John Stanley Hunter / Finance Forward for the talk.

Metric
Company Name	Angel Invest
Symbol
MSH ID	VENTURES:ANGELINVEST
Market	PRIVATE
Sector	Financial Services & Finance
Industry	Venture Capital
Country	EU
Stage
Employee Count	19
Website	angelinvest.ventures
LinkedIn	angel-invest-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	3.87K
Web Traffic Growth	1.14
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

ANGE

VENTURES:ANGELINVEST

Angel Invest

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue